| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f7ddc4774cf5f8a0bda44a780d73c53d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
| filingDate |
2008-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2012-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a68c68958af55377c8de92e6215d5f13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce2f0daa09839ade739dd52d340bc466
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_293e27d27a0044b4c50feaca8d5ac450
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff1d825c730f66f51c5032750c5cc327
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91ce7eebe8c0982ae6699f2f83883d8c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64672765fb16a7b42505f17d8374d3f4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15f1242ae7146b6badc9bc6c9008134d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_685ca4578cd3649ce369a4b61e7cf563
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a38dd9893430455ef27f8b272b2c73d |
| publicationDate |
2012-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2704815-C |
| titleOfInvention |
Methods for preparing capecitabine and beta-anomer-rich trialkyl carbonate compound used therein |
| abstract |
The present invention relates to a method for preparing capecitabine and a method for preparing a .beta.-anomer-rich trialkyl carbonate compound used therein, and a highly pure capecitabine can be efficiently prepared with a high yield by the method of the present invention using the .beta.-anomer-rich trialkyl carbonate compound as an intermediate. |
| priorityDate |
2007-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |